1 733 181 EFFECT OF MULA BANDHA YOGA IN MILD GRADE PELVIC ORGAN PROLAPSE: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: PELVIC ORGAN PROLAPSE IS THE GROWING HEALTH ISSUE RELATED TO WOMEN OF THE REPRODUCTIVE AND POSTMENOPAUSAL AGE GROUP IN INDIA AND ACROSS THE GLOBE. TREATMENT OPTION FOR PELVIC ORGAN PROLAPSE INCLUDES BOTH SURGICAL AND NON-SURGICAL INTERVENTION. THE DEVELOPMENT OF PELVIC ORGAN PROLAPSE IS AN INDICATION FOR MAJOR SURGERY AMONG 20% OF ALL WOMEN. NEVERTHELESS, THE RECURRENCE OF PELVIC ORGAN PROLAPSE IS DETECTED AMONG 58% OF THE PATIENT AFTER SURGERY. THIS HIGHLIGHTS THE NEED FOR PREVENTIVE MEASURES FOR REDUCING THE IMPACT OF PELVIC ORGAN PROLAPSE. AIMS AND OBJECTIVE: TO STUDY THE EFFECT OF 3 MONTHS YOGA THERAPY IN FEMALE PATIENTS SUFFERING FROM MILD PELVIC ORGAN PROLAPSE. MATERIAL AND METHODS: 50 PARTICIPANTS WERE ALLOCATED INTO TWO GROUPS (25 IN EACH GROUP) BY GENERATING RANDOM ALLOCATION SEQUENCE. WOMEN AGED 20-60 WITH SYMPTOMATIC MILD PELVIC ORGAN PROLAPSE IN THE YOGA GROUP WERE OFFERED MULABANDHA YOGA THERAPY ALONG WITH OTHER CONVENTIONAL TREATMENT MODALITIES, WHILE THE CONTROL GROUP WAS ONLY ON CONVENTIONAL TREATMENT. ALL PARTICIPANTS GAVE WRITTEN INFORMED CONSENT. AN ASSESSMENT WAS DONE BY IMPROVEMENT IN CHIEF COMPLAINTS AND PELVIC FLOOR DISTRESS INVENTORY-20 (PFDI-20) & PELVIC FLOOR IMPACT QUESTIONNAIRE-7 (PFIQ-7) AT BASELINE AND AT THE END OF 4, 8 & 12 WEEKS. RESULTS AT THE END OF 12 WEEKS, POST-STUDY COMPARISON BETWEEN THE TWO GROUPS SHOWED A SIGNIFICANT IMPROVEMENT IN CHIEF COMPLAINTS LIKE PERENNIAL PAIN, P/V DISCHARGE, PERINEAL MUSCLE LAXITY AND FEELING OF SOMETHING COMING OUT P/V (P < 0.001). PARTICIPANTS IN THE YOGA GROUP IMPROVED BY (ON AVERAGE) 5.7 (95% CONFIDENCE INTERVAL 3.1 TO 14.7) POINTS MORE ON THE PFDI-20 THAN DID PARTICIPANTS IN THE CONTROL GROUP (P = 0.1) AND A MEAN SCORE OF PFIQ-7 WAS ALSO IMPROVED SIGNIFICANTLY. CONCLUSIONS: ALTHOUGH MULABANDHA (ROOT LOCK) YOGA THERAPY LED TO A SIGNIFICANTLY GREATER IMPROVEMENT IN PFDI-20 & PFIQ-7 SCORES THE DIFFERENCE BETWEEN THE GROUPS WAS BELOW THE PRESUMED LEVEL OF CLINICAL RELEVANCE (15 POINTS). MORE STUDIES ARE NEEDED TO IDENTIFY FACTORS RELATED TO THE SUCCESS OF MULABANDHA (ROOT LOCK) YOGA THERAPY AND TO INVESTIGATE LONG-TERM EFFECTS. 2018 2 714 44 EFFECT OF INTEGRATED YOGA ON NEUROGENIC BLADDER DYSFUNCTION IN PATIENTS WITH MULTIPLE SCLEROSIS-A PROSPECTIVE OBSERVATIONAL CASE SERIES. BACKGROUND: NEUROGENIC BLADDER DYSFUNCTION (NBD) IS A COMMON DISTRESSFUL SYMPTOM IN MULTIPLE SCLEROSIS (MS) AFFECTING QUALITY OF LIFE. YOGA HAS BEEN WIDELY USED IN TREATING VARIOUS SYMPTOMS OF PATIENTS WITH MS. OBJECTIVES: TO EVALUATE THE EFFECT OF INTEGRATED YOGA FOR NBD IN PATIENTS WITH MS AS AN ADJUNCT TO STANDARD MEDICAL CARE. DESIGN: THIS OPEN ARM, PRE-POST STUDY DESIGN ASSESSED THE OUTCOME MEASURES AT BASE LINE AND AFTER 21 DAYS OF INTEGRATED YOGA INTERVENTION. SETTING: STUDY WAS CONDUCTED AT THE CENTER FOR NEUROLOGICAL REHABILITATION AT KWA-KLINIK STIFT ROTTAL IN BAD GRIESBACH, GERMANY. ELEVEN MS PATIENTS WITH NBD (MEAN AGE 46.7+/-11.24 YEARS) WITH MEAN DURATION 17.2 YEARS VOLUNTEERED TO PARTICIPATE IN THE STUDY. INTERVENTIONS: INTEGRATED YOGA WHICH INCLUDES PREPARATORY YOGIC LOOSENING AND BREATHING PRACTICES, NADISHUDDI PRANAYAMA (ALTERNATE NOSTRIL BREATHING), MOOLA BANDHA (ANAL LOCK), KAPALBHATI (RAPID NOSTRIL BREATHING) AND DEEP RELAXATION TECHNIQUE WAS GIVEN FOR 2H PER DAY FOR CONTINUOUS 21 DAYS. OUTCOME MEASURES: ULTRASOUND SCANNING FOR POST VOID RESIDUAL URINE VOLUME (PVR), MICTURITION CHECK LIST (MCL), INCONTINENCE IMPACT QUESTIONNAIRE-7 (IIQ-7) ANDUROGENITAL DISTRESS INVENTORY-6 (UDI-6) WERE USED. RESULTS: PAIRED SAMPLE T-TEST SHOWED SIGNIFICANT IMPROVEMENT IN POST VOID RESIDUAL URINE (62.34%, P<0.05), SCORES ON MICTURITION FREQUENCY CHECKLIST (25%, P<0.05), INCONTINENCE IMPACT QUESTIONNAIRE-7 (32.77%, P<0.05) AND URO-GENITAL DISTRESS INVENTORY-6 (26.33%, P<0.05). CONCLUSION: THIS STUDY POINTS TO THE SAFETY AND EFFECTIVENESS OF INTEGRATED YOGA FOR BLADDER SYMPTOMS AS AN ADJUNCT TO STANDARD CARE IN MULTIPLE SCLEROSIS PATIENTS WITH NEUROGENIC BLADDER DYSFUNCTION IN GERMANY. FURTHER TRAILS ARE NECESSARY TO CONFIRM THESE FINDINGS. 2012 3 1935 16 ROLE OF YOGA IN THE MANAGEMENT OF PREMATURE EJACULATION. PREMATURE EJACULATION (PE) IS A COMMON MALE SEXUAL PROBLEM. VARIOUS NON-PHARMACOLOGICAL AND PHARMACOLOGICAL TREATMENT OPTIONS ARE AVAILABLE CURRENTLY. THE IMPORTANCE OF YOGA IN THE MANAGEMENT OF VARIOUS SEXUAL DYSFUNCTIONS IS INCREASINGLY RECOGNIZED. IN THIS REVIEW, WE ARE ANALYZING THE ROLE OF YOGA IN THE MANAGEMENT OF PE. THIS PAPER EXPLORES THE MECHANISM OF YOGA PRACTICES IN THE MANAGEMENT OF PE AND THE RECOMMENDED YOGA PRACTICE FOR PE. IT ALSO DISCUSSES THE SCIENTIFIC EVIDENCE OF YOGA PRACTICES, SUCH AS YOGA POSTURES (YOGASANA), BREATHING PRACTICES (PRANAYAMA), LOCK (BANDHA), GESTURES (MUDRA), RELAXATION, AUM CHANTING, YOGA NIDRA AND MEDITATION WITH PARTICULAR REFERENCE THE MANAGEMENT OF PE. 2020 4 352 63 ASSESSMENT OF THE EFFECT OF MULABANDHA YOGA THERAPY IN HEALTHY WOMEN, STIGMATIZED FOR PELVIC FLOOR DYSFUNCTIONS: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: IN DEVELOPING COUNTRIES, WOMEN DO NOT REVEAL THEIR PERINEUM RELATED HEALTH ISSUES BECAUSE MOST OF THE TIME THEY ARE STIGMATIZED BY THE SOCIETY. MULTIPARITY, MOSTLY FOUND IN WOMEN OF RURAL AREAS IS ONE OF THE MAJOR CAUSES OF PELVIC FLOOR DYSFUNCTIONS (PFDS) LIKE PELVIC ORGAN PROLAPSE, URINARY INCONTINENCE, RECTAL INCONTINENCE, ETC. USUALLY, THEY VISIT HEALTH CENTRES IN THE ADVANCED STAGE OF DISEASES, AND THEN MEDICAL TREATMENT IS NOT THE ONLY CHOICE LEFT. MANY RESEARCH STUDIES SHOW THAT YOGA PRACTICES PROMOTE HEALTH CONDITIONS, CONTRIBUTE TO ENHANCING ENDURANCE, FLEXIBILITY, AND MUSCULAR STRENGTH, AND IMPROVING QUALITY OF LIFE. OBJECTIVE(S): THE STUDY WAS CONDUCTED TO ASSESS THE IMPACT OF MULABANDHA YOGA THERAPY (MYT) IN HEALTHY WOMAN PARTICIPANTS AS A PREVENTIVE MEASURE. MATERIAL AND METHODS: THE STUDY WAS A PROSPECTIVE AND RANDOMIZED CONTROLLED TRIAL. FIFTY HEALTHY WOMAN PARTICIPANTS WERE ALLOCATED IN TWO GROUPS VIZ., MYT GROUP AND NO MYT GROUP. MULABANDHA YOGA WAS CONDUCTED FOR THE MYT GROUP FOR 12 WEEKS. NO MYT GROUP WAS ADVISED NOT TO DO YOGA. PELVIC FLOOR MUSCLE STRENGTH WAS INTERNALLY EVALUATED BY EMPLOYING THE PERFECT SCHEME SCORE (P = POWER, E = ENDURANCE, R = REPETITIONS, F = FAST CONTRACTIONS, ECT = EVERY CONTRACTION TIMED). FOR ELIGIBLE SAMPLES, MYT SESSIONS WERE HELD FOR 12 WEEKS. DATA INTERPRETATION WAS DONE WITH SPSS SOFTWARE 20.0 (IBM CORP. RELEASED 2011. IBM SPSS STATISTICS FOR WINDOWS, VERSION 20.0. ARMONK, NY, USA). RESULTS: FIFTY HEALTHY WOMAN PARTICIPANTS WERE ALLOCATED FOR ANALYSIS. THERE WAS NO STATISTICALLY SIGNIFICANT DIFFERENCE IN BETWEEN THE GROUPS COMPARISON IN TERMS OF AGE, SOCIO-ECONOMIC STATUS, OCCUPATION, EDUCATION, PARITY AND MODE OF DELIVERY. PERFECT SCHEME SCORE SIGNIFICANTLY IMPROVED IN PARTICIPANTS AFTER 12 WEEKS OF REGULAR MYT. NO STATISTICALLY SIGNIFICANT DIFFERENCES WERE OBSERVED BETWEEN THE GROUPS COMPARISON IN TERMS OF PERFECT SCHEME SCORE. CONCLUSION: THE CURRENT STUDY SHOWS THAT REGULAR PRACTICE OF MYT FOR 12 WEEKS IS A BETTER MEANS TO REINFORCE THE STRENGTH OF PELVIC FLOOR MUSCLES IN WOMEN. THIS MYT PROCEDURE WILL ESTABLISH EVIDENCE FOR WOMEN WHO ARE RELUCTANT TOWARDS THEIR PELVIC ORGAN-RELATED ISSUES. WOMEN MUST INCORPORATE THE MYT PRACTICE IN THEIR ROUTINE LIFE AS A PREVENTIVE MEASURE TO REFRAIN FROM PELVIC FLOOR DYSFUNCTIONS. 2021 5 2004 34 STUDY OF IMMEDIATE NEUROLOGICAL AND AUTONOMIC CHANGES DURING KAPALBHATI PRANAYAMA IN YOGA PRACTITIONERS. BACKGROUND: KAPALBHATI IS A FAST PACE RESPIRATORY EXERCISE OR PRANAYAM, WHICH IS SUPPOSED TO BE PRACTICED BY YOGIS TO CLEAN THEIR BRAIN. PRANAYAMAS ARE WELL KNOWN TO IMPROVE HEART RATE VARIABILITY (HRV) ULTIMATELY LEADING TO BETTER AUTONOMIC FUNCTIONS. OTHER STUDIES HAVE OBSERVED THE IMMEDIATE EFFECT OF KAPALBHATI ON VARIOUS NEUROLOGICAL (BRAIN AND SPINE) AND AUTONOMIC FUNCTIONS, BUT THEIR RESULTS ARE VARIED AND INCONCLUSIVE. OBJECTIVE: THE AIM OF THIS STUDY IS TO FIND OUT THE CHANGES IN HRV AND BRAIN WAVES DURING AND AFTER PRACTICE OF KAPALBHATI AS COMPARED WITH THE BASELINE VALUES OF DIFFERENT PARAMETERS. METHODS: VARIOUS PARAMETERS WERE MEASURED AT BASELINE, DURING AND AFTER KAPALBHATI PRANAYAM WITH THE HELP OF DINAMIKA HRV-ADVANCED HRV TEST SYSTEM, MOSCOW, RUSSIA. STATISTICAL ANALYSIS WAS ACCOMPLISHED EMPLOYING REPEATED MEASURES ANALYSIS OF VARIANCE WITH BONFERRONI POST-HOC ANALYSIS AND HOLM'S MULTIPLE COMPARISONS USING THE VERSION 28.0.0.0 OF THE STATISTICAL PACKAGE FOR THE SOCIAL SCIENCES (SPSS) FOR WINDOWS (190) SPSS INC., CHICAGO. RESULTS: WE FOUND THAT DURING AND AFTER KAPALBHATI, CHANGES IN HRV WERE SIGNIFICANT IN TIME AND FREQUENCY DOMAIN SHOWING PARASYMPATHETIC WITHDRAWAL AND INSIGNIFICANT CHANGES IN BRAIN WAVES AS COMPARED WITH REFERENCE POINT VALUES. CONCLUSION: KAPALBHATI IS INITIALLY ENERGIZING, CLEANSING, AND HEATING. THERE OCCURS PARASYMPATHETIC WITHDRAWAL AND SYMPATHETIC ACTIVATION DURING PRANAYAMA. THERE IS AN INCREASE GAMMA WAVE ACTIVATION POST PRANAYAMA SHOWING CONTROL OF THE DEFAULT MODE NETWORK. 2022 6 1012 45 EFFECTS OF ONE MONTH OF COMMON YOGA PROTOCOL PRACTICE APPEAR TO BE MEDIATED BY THE ANGIOGENIC AND NEUROGENIC PATHWAY: A PILOT STUDY. OBJECTIVE: TO EXAMINE THE MOLECULAR EFFECTS OF MINDFUL ACTIVITIES SUCH AS YOGA AND MEDITATION DESIGN: THIS WAS AN OPEN LABEL SINGLE ARM EXPLORATORY YOGA INTERVENTION STUDY. STUDY PARTICIPANTS: 64 HEALTHY INDIVIDUALS WITHIN THE AGE OF 18-60 YEARS WERE RECRUITED FOR THIS ONE MONTH YOGA INTERVENTION STUDY. INTERVENTION: COMMON YOGA PROTOCOL (CYP) IS A STANDARDIZED YOGA PROTOCOL RELEASED BY MINISTRY OF AYUSH, INDIA FOR INTERNATIONAL YOGA DAY. IT INCLUDES ALL ASPECTS OF YOGA I.E. ASANAS, PRANAYAMA AND MEDITATION. IT IS DESIGNED FOR ADOPTION BY ALL AGE GROUPS FOR THE HEALTH OF COMMUNITY. OUTCOME MEASURES: THE PARTICIPANTS WERE ASSESSED FOR BIOCHEMICAL PARAMETERS INCLUDING FASTING SUGAR AND LIPID PROFILE. THE MOLECULAR MARKERS OF NEUROGENESIS (I.E. BRAIN DERIVED NEUROTROPIC FACTOR, BDNF) AND ANGIOGENESIS (I.E. VASCULAR ENDOTHELIAL GROWTH FACTOR, VEGF AND ANGIOGENIN) ALONG WITH AMYLOID BETA (MARKER RELATED TO NEURO-DEGENERATIVE DISEASES) WERE ASSESSED. ALL THE ASSESSMENTS WERE MADE AT BASELINE AND AFTER ONE MONTH OF THE INTERVENTION. RESULTS: AFTER ONE MONTH OF CYP PRACTICE HIGH DENSITY LIPOPROTEIN (HDL) LEVELS INCREASED SIGNIFICANTLY (P<0.001), ALTHOUGH OTHER BIOCHEMICAL PARAMETERS I.E. FASTING SUGAR AND OTHER LIPID ASSESSMENTS WERE FOUND TO BE UNALTERED. ANGIOGENESIS MARKER, ANGIOGENIN WAS INCREASED SIGNIFICANTLY (P<0.002), OTHER ANGIOGENESIS MARKER VEGF DID NOT SHOW ANY CHANGE ALONG WITH BDNF, MARKER OF NEUROGENESIS. AMYLOID BETA LEVELS WERE ALSO UNALTERED. EVEN THOUGH INDIVIDUAL LEVELS OF VEGF AND AMYLOID BETA DID NOT SHOW ANY CHANGE, PROPORTION OF VEGF TO AMYLOID BETA SHOWED A SIGNIFICANT INCREASE (P<0.001) AFTER ONE MONTH OF CYP INTERVENTION INDICATING THAT THE CHANGE IN VEGF LEVELS WAS SIGNIFICANTLY HIGHER THAN THE CHANGE IN AMYLOID BETA LEVELS. CONCLUSION: CYP PRACTICE MAY INFLUENCE CELL SURVIVAL PATHWAYS MEDIATED BY ANGIOGENIC AND NEUROGENIC CROSS TALK. HENCE, CYP CAN BE CONSIDERED AS A PREVENTIVE MEASURE FOR DISEASES ASSOCIATED WITH IMPAIRED ANGIOGENIC AND NEUROGENIC MECHANISM. THIS IS THE FIRST STUDY TO EXAMINE THE EFFECTS OF CYP AT THE MOLECULAR LEVEL. 2021 7 1399 40 IMPACT OF YOGA NIDRA ON MENSTRUAL ABNORMALITIES IN FEMALES OF REPRODUCTIVE AGE. OBJECTIVES: THE AIM OF THIS STUDY WAS TO OBSERVE THE EFFECT OF YOGA NIDRA PRACTICE ON HORMONE LEVELS IN PATIENTS WHO HAD MENSTRUAL IRREGULARITIES. DESIGN: THE STUDY WAS A RANDOMIZED CONTROLLED TRIAL. SETTINGS/LOCATION: THE STUDY WAS CONDUCTED IN THE DEPARTMENT OF OBSTETRICS AND GYNECOLOGY AT CHHATRAPATI SAHUJI MAHARAJ MEDICAL UNIVERSITY, UTTAR PRADESH, LUCKNOW, INDIA. SUBJECTS WERE DIVIDED RANDOMLY INTO 2 GROUPS-AN INTERVENTION AND A CONTROL GROUP, WITH 75 SUBJECTS IN EACH GROUP. OF THESE SUBJECTS, 126 COMPLETED THE STUDY PROTOCOL. SUBJECTS: THIS STUDY INVOLVED 150 SUBJECTS WITH MENSTRUAL IRREGULARITIES; 126 OF WHOM COMPLETED THE PROTOCOL. INTERVENTIONS: THE INTERVENTION WAS THE PRACTICE OF YOGA NIDRA. THE YOGIC INTERVENTION DURATION WAS 35-40 MINUTES/DAY, FIVE TIMES/WEEK FOR 6 MONTHS. AN ESTIMATION OF HORMONAL PROFILE WAS DONE FOR BOTH GROUPS AT BASELINE AND AFTER 6 MONTHS. RESULTS: THYROID-STIMULATING HORMONE (P<0.002), FOLLICLE-STIMULATING HORMONE (P<0.02), LUTEINIZING HORMONE (P<0.001), AND PROLACTIN (P<0.02) WERE DECREASED SIGNIFICANTLY IN THE INTERVENTION GROUP, COMPARED WITH THE CONTROL GROUP. CONCLUSIONS: THE PRESENT STUDY DEMONSTRATED THE EFFICACY OF YOGA NIDRA ON HORMONE PROFILES IN PATIENTS WITH MENSTRUAL IRREGULARITIES. YOGA NIDRA PRACTICE WAS HELPFUL IN PATIENTS WITH HORMONE IMBALANCES, SUCH AS DYSMENORRHEA, OLIGOMENORRHEA, MENORRHAGIA, METRORRHAGIA, AND HYPOMENORRHEA. 2013 8 496 35 COMBINATION OF AYURVEDA AND YOGA THERAPY REDUCES PAIN INTENSITY AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH MIGRAINE HEADACHE. OBJECTIVES: TO UNDERSTAND THE EFFICACY OF AYURVEDA AND YOGA IN THE MANAGEMENT OF MIGRAINE HEADACHE. METHODS: 30 SUBJECTS RECRUITED TO AYURVEDA AND YOGA (AY) GROUP UNDERWENT TRADITIONAL PANCHAKARMA (BIO-PURIFICATORY PROCESS) USING THERAPEUTIC PURGATION FOLLOWED BY YOGA THERAPY, WHILE 30 SUBJECTS OF CONTROL (CT) GROUP CONTINUED ON SYMPTOMATIC TREATMENT (NSAID'S) FOR 90 DAYS. BODY CONSTITUTION QUESTIONNAIRE WAS ADMINISTERED TO BOTH GROUPS. THE OUTCOME MEASURES INCLUDED SYMPTOM CHECK LIST, COMPREHENSIVE HEADACHE RELATED QUALITY OF LIFE QUESTIONNAIRE AND VISUAL ANALOGUE SCALE. RESULTS: FORTY-SIX (76.6%) OUT OF 60 SUBJECTS BELONGING TO BOTH GROUPS HAD PITTA BASED BODY CONSTITUTION. FOLLOWING 90 DAYS OF INTERVENTION THE AY GROUP SHOWED SIGNIFICANT REDUCTION IN MIGRAINE SYMPTOMS INCLUDING PAIN INTENSITY (P<.001) AND IMPROVEMENT IN HEADACHE RELATED QUALITY OF LIFE (P<.001). THE CT GROUP SHOWED NO SIGNIFICANT CHANGE (P>.05). CONCLUSION: TRADITIONAL AYURVEDA ALONG WITH YOGA THERAPY REDUCES SYMPTOMS, INTENSITY OF PAIN AND IMPROVES QUALITY OF LIFE IN MIGRAINE PATIENTS. 2018 9 689 48 EFFECT OF AYURVEDA INTERVENTION, LIFESTYLE MODIFICATION AND YOGA IN PREDIABETIC AND TYPE 2 DIABETES UNDER THE NATIONAL PROGRAMME FOR PREVENTION AND CONTROL OF CANCER, DIABETES, CARDIOVASCULAR DISEASES AND STROKE (NPCDCS)-AYUSH INTEGRATION PROJECT. BACKGROUND: TYPE 2 DIABETES IS A LIFESTYLE-RELATED DISORDER THAT AFFECTS AROUND 422 MILLION INDIVIDUALS IN INDIA. INTEGRATION OF AYUSH (AYURVEDA) WITH THE NATIONAL PROGRAMME FOR PREVENTION AND CONTROL OF CANCER, DIABETES, CARDIOVASCULAR DISEASES AND STROKE (NPCDCS) WAS CONCEIVED ON PILOT BASIS AT GAYA, BIHAR, TO PROVIDE INTEGRATIVE TREATMENT FOR NON-COMMUNICABLE DISEASE PATIENTS AND TO MANAGE THE BURDEN OF NON-COMMUNICABLE DISEASES IN INDIA. OBJECTIVES: THE OBJECTIVE OF THIS STUDY WAS TO ANALYZE THE EFFECT OF AYURVEDA INTERVENTION, LIFESTYLE MODIFICATION AND YOGA IN THE MANAGEMENT OF TYPE 2 DIABETES UNDER NPCDCS-AYUSH INTEGRATION PROJECT. MATERIALS AND METHODS: A MULTI-CENTRIC, OPEN-LABELED, PROSPECTIVE, COMPARATIVE CLINICAL STUDY WAS CONDUCTED AT 17 COMMUNITY HEALTH CENTERS AND 1 DISTRICT HOSPITAL. POPULATION OVER 30 YEARS OF AGE WAS SCREENED AND PREDIABETIC OR TYPE 2 DIABETIC INDIVIDUALS WERE ENROLLED IN TWO COHORTS, I.E., PRE-DIABETIC (COHORT A) AND TYPE 2 DIABETIC (COHORT B). EACH COHORT WAS FURTHER DIVIDED INTO TWO GROUPS: GROUP A1 WAS ADVISED FOR LIFESTYLE MODIFICATION AND YOGA AND GROUP A2 WAS GIVEN AYURVEDA MEDICATION IN ADDITION TO LIFESTYLE MODIFICATION AND YOGA. SIMILARLY, GROUP B1 WAS ADVISED FOR LIFESTYLE MODIFICATION AND YOGA ALONG WITH ALLOPATHIC MEDICATION AND GROUP B2 WAS GIVEN AYURVEDA MEDICATION, I.E., MAMAJJAKA, AMALAKI AND GUDUCHI POWDER IN ADDITION TO LIFESTYLE MODIFICATION AND YOGA ALONG WITH ALLOPATHIC MEDICATION. TREATMENT WAS GIVEN FOR 6 MONTHS. DATA WERE ANALYZED THROUGH PAIRED T-TEST. RESULTS: A SIGNIFICANT REDUCTION WAS OBSERVED IN FASTING BLOOD SUGAR LEVEL IN GROUPS A2 AND B2 (P = 0.001) AND ALSO IN THE POSTPRANDIAL BLOOD SUGAR LEVEL IN GROUPS A2 AND B2 (P = 0.001). FURTHER, IMPROVEMENT IN SUBJECTIVE SYMPTOMS SUCH AS POLYURIA, POLYDIPSIA, POLYPHAGIA, BLURRED VISION AND WEAKNESS WAS FOUND IN ALL THE GROUPS, WHILE NON-HEALING ULCER DOES NOT SHOW ANY IMPROVEMENT. CONCLUSION: THE STUDY REVEALS THAT AYURVEDA INTERVENTION, I.E., MAMAJJAKA CHURNA (1 G), AMALAKI CHURNA (3 G) AND GUDUCHI CHURNA (3 G) TWO TIMES A DAY EFFECTIVELY CONTROLS BLOOD SUGAR LEVEL IN PRE-DIABETIC AND TYPE 2 DIABETIC PATIENTS AND IMPROVES THE DISEASE MANAGEMENT WITH LIFESTYLE MODIFICATION AND YOGASANA AS WELL AS WITH ALLOPATHIC TREATMENT. 2019 10 1703 37 PARTITIONING OF RADIOLOGICAL, STRESS AND BIOCHEMICAL CHANGES IN PRE-DIABETIC WOMEN SUBJECTED TO DIABETIC YOGA PROTOCOL. BACKGROUND: YOGA IS AN ANCIENT SYSTEM OF WELLNESS WITH ASANA AND PRANAYAMA AS ITS MOST POPULAR AND PROPAGATED MODULES FOR MANAGEMENT OF LIFESTYLE DISORDERS. OBJECTIVES: THE AIM OF THE STUDY WAS TO CHARACTERISE THE LIVER ABNORMALITIES, BIOCHEMICAL CHANGES, AND STRESS LEVELS AFTER YOGA INTERVENTION IN PREDIABETIC FEMALES. MATERIALS AND METHODS: 37 FEMALES WERE RANDOMLY DIVIDED INTO YOGA PRACTISING AND NON-PRACTISING CONTROL GROUPS. THE YOGA PRACTISING GROUP PERFORMED DIABETIC YOGA PROTOCOL (DYP) FOR 3 MONTHS. PARAMETERS INCLUDING SIZE OF LIVER, FATTY INFILTRATION, AND GRADE OF SEVERITY WERE MEASURED USING ULTRASONOGRAPHY ALONG WITH BIOCHEMICAL PARAMETERS AND STRESS LEVELS AT BASELINE AND AFTER YOGA PRACTICE. RESULTS: THE GLYCOSYLATED HEMOGLOBIN (HBA1C) AND GLUCOSE LEVELS WERE FOUND SIGNIFICANTLY REDUCED IN PREDIABETIC (P=0.015) WOMEN AFTER PRACTISING DYP, ALTHOUGH CHOLESTEROL LEVELS INCREASED IN MENOPAUSAL WOMEN. NO ESCALATION OF FATTY LIVER WAS NOTED AMONG WOMEN PRACTISING DYP. CONCLUSION: DYP REDUCED THE HBA1C AND STRESS LEVELS AND THEREFORE, COULD BE A COST-EFFECTIVE TOOL FOR PREVENTING PREDIABETES TO DIABETES PROGRESSION. 2019 11 755 38 EFFECT OF SHORT-TERM YOGA-BASED-BREATHING ON PERI-OPERATIVE ANXIETY IN PATIENTS UNDERGOING CARDIAC SURGERY. BACKGROUND: PERI-OPERATIVE ANXIETY IN PATIENTS SCHEDULED FOR CARDIAC SURGERY IS DETRIMENTAL. THIS STUDY EVALUATED THE EFFECT OF SHORT-TERM YOGA BASED-BREATHING WITH DIFFERENT VARIATIONS ON PERI-OPERATIVE ANXIETY. MATERIALS AND METHODS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY WAS CONDUCTED IN PATIENTS AGED 20-60 YEARS SCHEDULED FOR MAJOR CARDIAC SURGERY. PATIENTS IN YOGA GROUP WERE TRAINED FOR YOGA BASED-BREATHING WITH DIFFERENT VARIATIONS FOR 5 DAYS; NO INTERVENTION WAS DONE IN CONTROLS. RESULTS: WE ANALYZED TWENTY PATIENTS IN EACH GROUP. ANXIETY SCORES MEASURED AT BASELINE, PRESURGERY, AND POSTSURGERY WERE ENTERED AS THE WITHIN-SUBJECTS FACTOR; GROUP STATUS WAS ENTERED AS THE BETWEEN-SUBJECTS FACTOR IN THE RMANOVA. BASELINE DEMOGRAPHICS AND ANXIETY SCORES WERE COMPARABLE. THE SHORT-TERM YOGA-BASED BREATHING EXERCISE-TRAINING PROGRAM HAD A STATISTICALLY SIGNIFICANT EFFECT ON STATE (F = 13.45, P < 0.0001), TRAIT (F = 13.29, P < 0.0001) AND TOTAL ANXIETY SCORES (F = 29.44, P < 0.0001) AT DIFFERENT TIME POINTS FOR YOGA OVER CONTROL GROUP. CONCLUSION: SHORT-TERM YOGA-BASED BREATHING FOR 5 DAYS LOWERS PRESURGERY AND POSTSURGERY ANXIETY IN PATIENTS UNDERGOING CARDIAC SURGERY. 2021 12 1125 40 EFFICACY OF SHORT-TERM YOGA THERAPY PROGRAM ON QUALITY OF LIFE IN PATIENTS WITH PSYCHOSOMATIC AILMENTS. OBJECTIVE: THE AIM WAS TO STUDY THE EFFECT OF SHORT-TERM YOGA THERAPY PROGRAM ON QUALITY OF LIFE IN PATIENTS SUFFERING FROM PSYCHOSOMATIC AILMENTS. METHODS: SAMPLE SIZE AND STUDY PERIOD: ALL THE SUBJECTS COMING TO SVYASA AROGYADHAMA IN MONTH OF JULY 2011 FOR YOGA THERAPY FOR VARIOUS PSYCHOSOMATIC AILMENTS AND WERE FREE OF ANY PRIMARY PSYCHIATRIC ILLNESS AND VOLUNTEERING TO PARTICIPATE WERE ENROLLED IN THE STUDY AFTER TAKING INFORMED CONSENT. THEIR PHYSICAL CONDITION WAS HEALTHY ENOUGH TO PRACTICE YOGA AS JUDGED CLINICALLY. ALL SUBJECTS (N = 94) WHO WERE ENROLLED IN THE STUDY UNDERWENT INTEGRATED APPROACH TO YOGA THERAPY, WHICH INCLUDED ASANAS, PRANAYAMAS, MEDITATION, KRIYAS AND LECTURES ON PRACTICE OF YOGA AND DERIVED SPECIAL TECHNIQUES IN THEIR RESPECTIVE SECTIONS. THE QUALITY OF LIFE WAS ASSESSED BY SF-12 QUESTIONNAIRE AND THEREBY CALCULATING PHYSICAL AND MENTAL COMPOSITE SCORES (PCS AND MCS) BEFORE AND AFTER 1 WEEK OF YOGA THERAPY. DATA THUS OBTAINED WAS ANALYZED USING PAIRED T-TEST. RESULTS: A SIGNIFICANT IMPROVEMENT (P < 0.001) WAS SEEN IN THE STUDY GROUP IN BOTH PCS (FROM MEAN +/- SD OF 37.50 +/- 9.58 TO 43.7 +/- 8.73) AND MCS (FROM 45.87 +/- 9.57 TO 53.35 +/- 7.9.) WITH MINOR VARIATIONS IN PATIENTS OF VARIOUS DEPARTMENTS. CONCLUSION: A SHORT-TERM YOGA THERAPY PROGRAM LEADS TO A REMARKABLE IMPROVEMENT IN THE QUALITY OF LIFE OF THE SUBJECTS AND CAN CONTRIBUTE FAVORABLY IN THE MANAGEMENT OF PSYCHOSOMATIC DISORDERS. 2015 13 2669 34 YOGA IN MALE SEXUAL FUNCTIONING: A NONCOMPARARIVE PILOT STUDY. INTRODUCTION: YOGA IS PRACTICED BOTH IN DEVELOPING AND DEVELOPED COUNTRIES. MANY PATIENTS AND YOGA PROTAGONISTS CLAIM THAT IT IS USEFUL IN IMPROVING SEXUAL FUNCTIONS AND TREATING SEXUAL DISORDERS. AIM: WE WANTED TO STUDY THE EFFECT OF YOGA ON MALE SEXUAL FUNCTIONING. METHODS: WE STUDIED 65 MALES (AGE RANGE= 24-60 YEARS, AVERAGE AGE=40+/-8.26 YEARS) WHO WERE ENROLLED IN A YOGA CAMP AND ADMINISTERED A KNOWN QUESTIONNAIRE, I.E., MALE SEXUAL QUOTIENT (MSQ) BEFORE AND AFTER 12 WEEKS SESSION OF YOGA. MAIN OUTCOME MEASURES: MSQ SCORES BEFORE AND AFTER YOGA SESSIONS. RESULTS: IT WAS FOUND THAT AFTER THE COMPLETION OF YOGA SESSIONS, THE SEXUAL FUNCTIONS SCORES WERE SIGNIFICANTLY IMPROVED (P<0.0001). THE IMPROVEMENT OCCURRED IN SCORES OF ALL THE DOMAINS OF SEXUAL FUNCTIONS AS STUDIED BY MSQ (DESIRE, INTERCOURSE SATISFACTION, PERFORMANCE, CONFIDENCE, PARTNER SYNCHRONIZATION, ERECTION, EJACULATORY CONTROL, ORGASM). CONCLUSIONS: YOGA APPEARS TO BE AN EFFECTIVE METHOD OF IMPROVING ALL DOMAINS OF SEXUAL FUNCTIONS IN MEN AS STUDIED BY MSQ. 2010 14 1136 41 EFFICACY OF YOGA ON PREGNANCY OUTCOME. OBJECTIVE: TO STUDY THE EFFICACY OF YOGA ON PREGNANCY OUTCOMES. DESIGN AND SETTING: THREE HUNDRED THIRTY FIVE (335) WOMEN ATTENDING THE ANTENATAL CLINIC AT GUNASHEELA SURGICAL AND MATERNITY HOSPITAL IN BANGALORE, INDIA, WERE ENROLLED BETWEEN 18 AND 20 WEEKS OF PREGNANCY IN A PROSPECTIVE, MATCHED, OBSERVATIONAL STUDY; 169 WOMEN IN THE YOGA GROUP AND 166 WOMEN IN THE CONTROL GROUP. METHODS: WOMEN WERE MATCHED FOR AGE, PARITY, BODY WEIGHT, AND DOPPLER VELOCIMETRY SCORES OF UMBILICAL AND UTERINE ARTERIES. YOGA PRACTICES, INCLUDING PHYSICAL POSTURES, BREATHING, AND MEDITATION WERE PRACTICED BY THE YOGA GROUP ONE HOUR DAILY, FROM THE DATE OF ENTRY INTO THE STUDY UNTIL DELIVERY. THE CONTROL GROUP WALKED 30 MINUTES TWICE A DAY (STANDARD OBSTETRIC ADVICE) DURING THE STUDY PERIOD. COMPLIANCE IN BOTH GROUPS WAS ENSURED BY FREQUENT TELEPHONE CALLS AND STRICT MAINTENANCE OF AN ACTIVITY DIARY. MAIN OUTCOMES: BIRTH WEIGHT AND GESTATIONAL AGE AT DELIVERY WERE PRIMARY OUTCOMES. RESULTS: THE NUMBER OF BABIES WITH BIRTH WEIGHT > OR = 2500 GRAMS WAS SIGNIFICANTLY HIGHER (P < 0.01) IN THE YOGA GROUP. PRETERM LABOR WAS SIGNIFICANTLY LOWER (P < 0.0006) IN THE YOGA GROUP. COMPLICATIONS SUCH AS ISOLATED INTRAUTERINE GROWTH RETARDATION (IUGR) (P < 0.003) AND PREGNANCY-INDUCED HYPERTENSION (PIH) WITH ASSOCIATED IUGR (P < 0.025) WERE ALSO SIGNIFICANTLY LOWER IN THE YOGA GROUP. THERE WERE NO SIGNIFICANT ADVERSE EFFECTS NOTED IN THE YOGA GROUP. CONCLUSIONS: AN INTEGRATED APPROACH TO YOGA DURING PREGNANCY IS SAFE. IT IMPROVES BIRTH WEIGHT, DECREASES PRETERM LABOR, AND DECREASES IUGR EITHER IN ISOLATION OR ASSOCIATED WITH PIH, WITH NO INCREASED COMPLICATIONS. 2005 15 2666 43 YOGA IN FEMALE SEXUAL FUNCTIONS. INTRODUCTION: YOGA IS A POPULAR FORM OF COMPLEMENTARY AND ALTERNATIVE THERAPY. IT IS PRACTICED BOTH IN DEVELOPING AND DEVELOPED COUNTRIES. FEMALE SEXUAL DYSFUNCTIONS ARE COMMON AND DO NOT ALWAYS GET ADEQUATE CLINICAL ATTENTION. PHARMACOTHERAPIES FOR TREATING FEMALE SEXUAL DYSFUNCTIONS ARE AVAILABLE BUT SUFFER FROM DRAWBACKS SUCH AS POOR COMPLIANCE, LOW EFFICACY, AND SIDE EFFECTS. MANY PATIENTS AND YOGA PROTAGONISTS CLAIM THAT IT IS USEFUL IN IMPROVING SEXUAL FUNCTIONS AND TREATING SEXUAL DISORDERS. AIM: TO ESTABLISH THE EFFECT YOGA CAN HAVE ON FEMALE SEXUAL FUNCTIONS. METHODS: WE RECRUITED 40 FEMALES (AGE RANGE 22-55 YEARS, AVERAGE AGE 34.7 +/- 8.49 YEARS) WHO WERE ENROLLED IN A YOGA CAMP AND WERE GIVEN A STANDARDIZED QUESTIONNAIRE NAMED FEMALE SEXUAL FUNCTION INDEX (FSFI) BEFORE AND AFTER THE 12 WEEKS SESSION OF YOGA. MAIN OUTCOME MEASURES: FSFI SCORES. RESULTS: IT WAS FOUND THAT AFTER THE COMPLETION OF YOGA SESSIONS; THE SEXUAL FUNCTIONS SCORES WERE SIGNIFICANTLY IMPROVED (P < 0.0001). THE IMPROVEMENT OCCURRED IN ALL SIX DOMAINS OF FSFI (I.E., DESIRE, AROUSAL, LUBRICATION, ORGASM, SATISFACTION, AND PAIN). THE IMPROVEMENT WAS MORE IN OLDER WOMEN (AGE > 45 YEARS) COMPARED WITH YOUNGER WOMEN (AGE < 45 YEARS). CONCLUSIONS: YOGA APPEARS TO BE AN EFFECTIVE METHOD OF IMPROVING ALL DOMAINS OF SEXUAL FUNCTIONS IN WOMEN AS STUDIED BY FSFI. 2010 16 740 32 EFFECT OF RAJYOGA MEDITATION ON CHRONIC TENSION HEADACHE. CHRONIC TENSION-TYPE HEADACHE (CTTH) IS THE MOST COMMON TYPE OF HEADACHE WITH NO TRULY EFFECTIVE TREATMENT. THIS STUDY WAS DESIGNED TO CORRELATE THE ADDITIVE EFFECT OF MEDITATION ON CTTH PATIENTS RECEIVING MEDICAL TREATMENT. 50 PATIENTS (AGED 18-58 YEARS) PRESENTING WITH A CLINICAL DIAGNOSIS OF CCTH, WERE DIVIDED IN 2 GROUPS. GROUP 1 (N=30) RECEIVED 8 LESSONS AND PRACTICAL DEMONSTRATION OF BRAHMAKUMARIS SPIRITUAL BASED MEDITATION KNOWN AS RAJYOGA MEDITATION FOR RELAXATION THERAPY, IN ADDITION TO ROUTINE MEDICAL TREATMENT (ANALGESICS AND MUSCLE RELAXANTS). GROUP 2 (N=20) PATIENTS RECEIVED ANALGESICS AND MUSCLE RELAXANTS TWICE A DAY BUT NO RELAXATION THERAPY IN THE FORM OF MEDITATION. BOTH GROUPS WERE FOLLOWED UP FOR 8 WEEKS PERIOD. THE PARAMETERS STUDIED WERE SEVERITY, FREQUENCY AND DURATION OF CCTH, AND THEIR HEADACHE INDEX CALCULATED. PATIENTS IN BOTH GROUPS SHOWED A HIGHLY SIGNIFICANT REDUCTION IN HEADACHE VARIABLES (P<0.001) AFTER 8 WEEKS. BUT THE PERCENTAGE OF PATIENTS SHOWING HIGHLY SIGNIFICANT RELIEF IN SEVERITY OF HEADACHE, DURATION & FREQUENCY IN GROUP 1 WAS 94%, 91% AND 97% RESPECTIVELY WHEREAS IN GROUP 2 IT WAS 36%, 36% AND 49% RESPECTIVELY. HEADACHE RELIEF AS CALCULATED BY HEADACHE INDEX WAS 99% IN GROUP 1 AS COMPARED TO 51% IN GROUP 2. EVEN SHORT TERM SPIRITUAL BASED RELAXATION THERAPY (RAJYOGA MEDITATION) WAS HIGHLY EFFECTIVE IN CAUSING EARLIER RELIEF IN CHRONIC TENSION HEADACHE AS MEASURED BY HEADACHE PARAMETER. 2014 17 453 38 CHANGES IN MIDAS, PERCEIVED STRESS, FRONTALIS MUSCLE ACTIVITY AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS USAGE IN PATIENTS WITH MIGRAINE HEADACHE WITHOUT AURA FOLLOWING AYURVEDA AND YOGA COMPARED TO CONTROLS: AN OPEN LABELED NON-RANDOMIZED STUDY. BACKGROUND: THERE HAS BEEN A SIGNIFICANT INCREASE IN THE USE OF COMPLEMENTARY AND INTEGRATIVE MEDICINE TO PROVIDE LONG-TERM HEALING SOLUTIONS IN MIGRAINE HEADACHE PATIENTS. KNOWING THE LIMITATIONS OF CONVENTIONAL MEDICAL APPROACH, THE PRESENT STUDY EVALUATED THE INFLUENCE OF TWO INDIAN TRADITIONAL SYSTEMS OF MEDICINE ON MIGRAINE-RELATED DISABILITY, AUTONOMIC VARIABLES, PERCEIVED STRESS, AND MUSCLE ACTIVITY IN PATIENTS WITH MIGRAINE HEADACHE WITHOUT AURA. METHODS: THIRTY SUBJECTS RECRUITED TO THE AYURVEDA AND YOGA (AY) GROUP UNDERWENT TRADITIONAL PANCHAKARMA (BIO-PURIFICATION) USING THERAPEUTIC PURGATION FOLLOWED BY YOGA THERAPY, WHILE 30 SUBJECTS OF CONTROL (CT) GROUP CONTINUED ON SYMPTOMATIC TREATMENT (NON-STEROIDAL ANTI-INFLAMMATORY DRUGS [NSAID'S]) FOR 90 DAYS. MIGRAINE DISABILITY ASSESSMENT SCORE, PERCEIVED STRESS, HEART RATE VARIABILITY (HRV), AND SURFACE ELECTROMYOGRAPHY (EMG) OF FRONTALIS MUSCLE WERE MEASURED ON DAY 1, DAY 30, AND DAY 90 IN BOTH GROUPS. RESULTS: SIGNIFICANT REDUCTION IN MIGRAINE DISABILITY AND PERCEIVED STRESS SCORES WERE OBSERVED IN THE AY GROUP. THE LOW-FREQUENCY COMPONENT OF THE HRV DECREASED SIGNIFICANTLY, THE HIGH-FREQUENCY COMPONENT INCREASED AND THEIR RATIO SHOWED IMPROVED SYMPATHOVAGAL BALANCE. THE EMG SHOWED DECREASED ACTIVITY OF THE FRONTALIS MUSCLE IN THE AY GROUP COMPARED TO THE CONTROL GROUP. CONCLUSION: THE INTEGRATIVE APPROACH COMBINING AYURVEDA AND YOGA THERAPY REDUCES MIGRAINE-RELATED DISABILITY, PERCEIVED STRESS, SYMPATHETIC AROUSAL, AND MUSCLE TENSION. 2018 18 624 35 DIABETES MELLITUS TYPE 2 AND YOGA: ELECTRO PHOTONIC IMAGING PERSPECTIVE. BACKGROUND: YOGA IS THE MOST POPULAR FORM OF ALTERNATIVE MEDICINE FOR THE MANAGEMENT OF DIABETES MELLITUS TYPE 2. THE ELECTRO-PHOTONIC IMAGING (EPI) IS ANOTHER CONTRIBUTION FROM ALTERNATIVE MEDICINE IN HEALTH MONITORING. AIM: TO EVALUATE DIABETES FROM EPI PERSPECTIVE. OBJECTIVES: (1) COMPARE VARIOUS EPI PARAMETERS IN NORMAL, PREDIABETIC AND DIABETIC PATIENTS. (2) FIND DIFFERENCE IN CONTROLLED AND UNCONTROLLED DIABETES. (3) STUDY THE EFFECT OF 7 DAYS DIABETES-SPECIFIC YOGA PROGRAM. MATERIALS AND METHODS: FOR THE FIRST OBJECTIVE, THERE WERE 102 PATIENTS (NORMAL 29, PREDIABETIC 13, DIABETIC 60). IN THE SECOND STUDY, THERE WERE 60 PATIENTS (CONTROLLED DIABETES 27, UNCONTROLLED DIABETES 33). THE THIRD STUDY COMPRISED 37 PATIENTS. EPI PARAMETERS WERE RELATED TO GENERAL HEALTH AS WELL TO SPECIFIC ORGANS. RESULTS: IN THE FIRST STUDY, SIGNIFICANT DIFFERENCE WAS OBSERVED BETWEEN (1) DIABETICS AND NORMAL: AVERAGE INTENSITY 5.978, FORM COEFFICIENT 3.590, IMMUNE ORGANS 0.281 ALL P < 0.001; (2) DIABETICS AND PREDIABETICS: AVERAGE INTENSITY 6.676, FORM COEFFICIENT 4.158, IMMUNE ORGANS 5.890 P < 0.032; (3) NORMAL AND PREDIABETES: IMMUNE ORGANS (-6.171 P = 000). IN THE SECOND STUDY, REMARKABLE DIFFERENCE WAS IN THE IMMUNE ORGANS (0.201, P = 0.031). IN THE PRE- AND POST-STUDY, THE MEAN DIFFERENCE WAS: AREA 630.37, FORM COEFFICIENT 1.78, ENTROPY 0.03, LIVER 0.24, PANCREAS 0.17, CORONARY VESSELS 0.11, AND LEFT KIDNEY 29, WITH ALL P < 0.02. CONCLUSION: THERE IS A SIGNIFICANT DIFFERENCE IN EPI PARAMETERS BETWEEN NORMAL, PREDIABETICS AND DIABETICS, THE PROMINENT BEING AVERAGE INTENSITY, FORM COEFFICIENT, AND IMMUNE ORGANS. BETWEEN CONTROLLED AND UNCONTROLLED DIABETES, IMMUNE ORGANS SHOW SIGNIFICANT CHANGE. INTERVENTION OF YOGA RESULTS IN CHANGE IN MOST PARAMETERS. 2017 19 2672 37 YOGA IN PREMATURE EJACULATION: A COMPARATIVE TRIAL WITH FLUOXETINE. INTRODUCTION: YOGA IS A POPULAR FORM OF COMPLEMENTARY AND ALTERNATIVE TREATMENT. IT IS PRACTICED BOTH IN DEVELOPING AND DEVELOPED COUNTRIES. USE OF YOGA FOR VARIOUS BODILY AILMENTS IS RECOMMENDED IN ANCIENT AYVURVEDIC (AYUS = LIFE, VEDA = KNOWLEDGE) TEXTS AND IS BEING INCREASINGLY INVESTIGATED SCIENTIFICALLY. MANY PATIENTS AND YOGA PROTAGONISTS CLAIM THAT IT IS USEFUL IN SEXUAL DISORDERS. WE ARE INTERESTED IN KNOWING IF IT WORKS FOR PATIENTS WITH PREMATURE EJACULATION (PE) AND IN COMPARING ITS EFFICACY WITH FLUOXETINE, A KNOWN TREATMENT OPTION FOR PE. AIM: TO KNOW IF YOGA COULD BE TRIED AS A TREATMENT OPTION IN PE AND TO COMPARE IT WITH FLUOXETINE. METHODS: A TOTAL OF 68 PATIENTS (38 YOGA GROUP; 30 FLUOXETINE GROUP) ATTENDING THE OUTPATIENT DEPARTMENT OF PSYCHIATRY OF A TERTIARY CARE HOSPITAL WERE ENROLLED IN THE PRESENT STUDY. BOTH SUBJECTIVE AND OBJECTIVE ASSESSMENT TOOLS WERE ADMINISTERED TO EVALUATE THE EFFICACY OF THE YOGA AND FLUOXETINE IN PE. THREE PATIENTS DROPPED OUT OF THE STUDY CITING THEIR INABILITY TO COPE UP WITH THE YOGA SCHEDULE AS THE REASON. MAIN OUTCOME MEASURE: INTRAVAGINAL EJACULATORY LATENCIES IN YOGA GROUP AND FLUOXETINE CONTROL GROUPS. RESULTS: WE FOUND THAT ALL 38 PATIENTS (25-65.7% = GOOD, 13-34.2% = FAIR) BELONGING TO YOGA AND 25 OUT OF 30 OF THE FLUOXETINE GROUP (82.3%) HAD STATISTICALLY SIGNIFICANT IMPROVEMENT IN PE. CONCLUSIONS: YOGA APPEARS TO BE A FEASIBLE, SAFE, EFFECTIVE AND ACCEPTABLE NONPHARMACOLOGICAL OPTION FOR PE. MORE STUDIES INVOLVING LARGER PATIENTS COULD BE CARRIED OUT TO ESTABLISH ITS UTILITY IN THIS CONDITION. 2007 20 1178 31 EVALUATION OF STAMBHANAKARAKA YOGA AND COUNSELING IN THE MANAGEMENT OF SHUKRAGATA VATA (PREMATURE EJACULATION). PREMATURE EJACULATION (PE) IS A VERY COMMON MALE SEXUAL PROBLEM. ANXIETY, STRESS, FEAR ETC., ARE THE MAIN PREDISPOSING FACTORS OF PE. IN AYURVEDA, THIS CONDITION CAN BE CORRELATED WITH SHUKRAGATA VATA. IN THE PRESENT STUDY, FIFTY FIVE PATIENTS WITH PE WERE GROUPED INTO TWO AND WERE TREATED WITH STAMBHANAKARAKA YOGA (N = 30) AND PLACEBO (N = 20) FOR A DURATION OF TWO MONTHS, WITH LUKE WARM WATER AS ANUPANA. PSYCHOLOGICAL COUNSELING WAS GIVEN TO THE PATIENTS IN BOTH THE GROUPS. AFTER COMPLETION OF TREATMENT, STAMBHANAKARAKA YOGA SHOWED SIGNIFICANT RESULTS AGAINST PLACEBO IN ALL PARAMETERS, NAMELY INTRAVAGINAL EJACULATION LATENCY TIME (IELT), VOLUNTARY CONTROL OVER EJACULATION, PATIENT AND PARTNER'S SATISFACTION, PERFORMANCE ANXIETY. 2013